TEVA DENMARK A/S: Financial statements 2020
CVR: 29634076
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
TEVA DENMARK A/S (CVR 29634076) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 529,350,000 and a net result of DKK -29,295,000 compared with DKK 3,387,000 the year before. That is a decrease of 6% compared with the year before. The profit margin was -5.5%. Equity in the 2020 report amounted to DKK 142,653,000. The solvency ratio was 50.4%. The company had 39 employees in the financial year.
- Revenue
- DKK 529,350,000
- Gross Profit
- DKK 49,014,000
- Profit/Loss
- DKK -29,295,000
- Equity
- DKK 142,653,000
- Total Assets
- DKK 282,988,000
- Employees
- 39
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 529.4 mio. | 49 mio. | -29.3 mio. | 142.7 mio. | 39 |
| 2019 | 563 mio. | 40.1 mio. | 3.4 mio. | 127.3 mio. | 36 |
| 2018 | 586.5 mio. | 61.9 mio. | 14.7 mio. | 123.9 mio. | 47 |
| 2017 | - | 42.7 mio. | 2.6 mio. | 53.6 mio. | 29 |
| 2016 | - | 31.2 mio. | 4.8 mio. | 51.1 mio. | 28 |
Official annual report
How creditworthy is TEVA DENMARK A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 31, 2020, Henri Pieter Josephus Henrichs has left the board of directors of TEVA DENMARK A/S.
TEVA DENMARK A/S has published its annual report for 2019. Revenue came to DKK 563,009,000, and the net result was DKK 3,387,000.
About TEVA DENMARK A/S
TEVA DENMARK A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Morten Nielsen and Bjarne Palle Niemi. The board consists of Helle Grinderslev Kramp, Mirko Vonk and Morten Nielsen. The company is owned by Teva Pharma B.V.. The company has 39 employees (2018). In 2025, the company reported revenue of DKK 645,331,000 and a net result of DKK 46,817,000 compared with DKK 57,422,000 the year before. Equity in the 2025 report amounted to DKK 113,670,000.